Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > Key Differential
View:
Post by Oldweed on Nov 04, 2022 11:51am

Key Differential

CURA has taken a similar approach to LP's with 2 major factors that differentiate them:

LP's invested with the intent to be a major player in the USA and are now running out of time, CURA is already in the USA making tons of cash.

CURA also looked to international investment in Germany, now legalized so early player in yet another massive market.

Hard not to see the advantages!
Comment by TheProphetElijah on Nov 04, 2022 12:35pm
What I don't like about Cura is it's liabilities to assets ratio 1.7 b liability 3.5 b assets =48% This is high, especially in a rising rate environment.  Around 30% is ok. Plays like PLTH sit at 13%.   But I dunno maybe that's too simplistic an analysis.
Comment by Oldweed on Nov 04, 2022 12:41pm
Yep, CURA has debt (what I was reffering to with the same game plan as the LP's) but it has the US market and sales to maintain that debt. CURA is at the end of a big growth phase and now is entering a more mature US market phase. With less capital required in the US it can easily turn a profit even before the 280e issue is resolved. They will soon have that issue removed and will be insanely ...more  
Comment by Oldweed on Nov 04, 2022 12:45pm
Keep in mind they might even be on track to exceed 1.7B in annual revenue, vs the 1.6B debt load!
Comment by Sampic on Nov 04, 2022 1:17pm
Cura costs are high because of the current legal status in 5 years Cura won't even grow cannabis just like Starbucks doesn't grow coffee beans Louis Vuitton doesn't grow cotton and Grey gooose doesn't grow grain.Limited licence locations Branding and first movers advantage are the key to the business.Revenues will continue to rise and costs will fall by 90 percent once this happens ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities